Substituted amines synergistic with tobramycin against burkholderia cepacia in vitro

Chemotherapy

Volumn 43, Issue 2, 1997, Pages 100-107

  Cohn, Robert C ^a   Rudzienski, Lois ^a  

^a CHILDREN S MEDICAL CENTER   (United States)

Author keywords

Amines; Burkholderia cepacia; Cystic fibrosis; Synergy; Tobramycin

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMINE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; DICHLORISOPRENALINE; IMIDAZOLINE; PHENOTHIAZINE DERIVATIVE; PROPRANOLOL; THIOXANTHENE DERIVATIVE; TOBRAMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BURKHOLDERIA CEPACIA; DRUG POTENTIATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0031039201     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239543     Document Type: Article

References (11)

1. Thomassen MJ, Denko CA, Doershuk CF: Cystic Fibrosis: A review of pulmonary infections and interventions. Pcdiatr Pulmonol 1987:3: 334-351.
2. Cohn RC, Jacobs M, Aronof TSC: In vitro activity of amiloride combined with tobramycin against Pseudomonas isolates from patients with cystic Fibrosis. Antimicrob Agents Chemother 1988;32:395-396.
3. Cohn RC, Rudzienski L, Putnam RW: Verapamil-tobramycin synergy in Pseudomonas cepacia but not Pseudomonas aeruginosa in vitro. Chemotherapy 1995;41:330-333.
4. Muszynski M, Rajyaguru JM: Unique mechanism of enhanced antibiotic susceptibility by cationic agents against Pseudomonas cepacia (abstract). Pediatr Pulmonol 1993; suppl 9:225.
5. Rajyaguru JM, Muszynski M: Sensitization of Burkhoideria cepacia (Pseudomonas cepacia) due to outer membrane permeability alteration by cationic drugs (abstract). Pcdiatr Pulmonol 1994;suppl 10:274.
6. Cohn RC, Aronoff SC: The effect of sodium on amiloridc-tobramycin synergy on Pseudomonas cepacia. J Lab Clin Med 1989; 114:724-727.
7. Cohn RC, Rudzienski L: Observation on amiloridc-tobramycin synergy in Pseudomonas cepacia. Curr f her Res 1991:50:786-793.
8. Ccderlund H, Mardh P: Antibacterial activities of non-antibiotic drugs. J Antimicrob Chemother 1993;32:355-365.
9. Mentz WM, Brown JB, Friedman M, Stutts MJ, Gatzy JT, Boucher RC: Deposition, clearance, and effects of aerosolized amiloride in sheep airways. Am Rev Respir Dis 1986;134:938-943.
10. Knowles MR, Church NL, Waltner WE, Yankaskas JR, Gilligan P, King M, Edwards LJ, Helms RW, Boucher RC: A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N Engl J Med 1990;322:1189-1194.
11. Ramsey BW, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Kravitz RM, Schidlow DV, Wilmott RW, Astley SJ, McBurnie MA, Wentz K, Smith AL: Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N Engl J Med 1993,328: 1740-1746.